Illicit Drug Use and HIV Treatment Outcomes in a U.S. Cohort
February 22, 2008
The goal of the current study was to assess the prevalence of illicit drug use and the impact of HIV treatment using multivariable regression of cross-sectional data from participants in the Study of Fat Redistribution and Metabolic Change in HIV Infection.
"Illicit drug use in the US is common, although far fewer report current use than past use. Among HIV-infected patients, understanding the type of illicit drug used and whether drug use was in the past or ongoing is important because of their differential effects on treatment outcomes," the researchers concluded.
01.30.2008; Vol. 22; No. 3: P. 357-365; Joseph Cofrancesco, Jr.; Rebecca Scherzer; Phyllis C. Tien; Cynthia L. Gibert; Heather Southwell; Stephen Sidney; Adrian Dobs; Carl Grunfeld
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.